Cinacalcet in patients on peritoneal dialysis with moderate to severe hyperparathyroidism resistant to conventional treatment. A one-year, prospective study
Cinacalcet en pacientes en diálisis peritoneal con hiperparatiroidismo moderado-severo resistentes a tratamiento convencional. Estudio prospectivo a un año.
Read
9644
Timeswas read the article
2784
Total PDF
6860
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 152 | 36 | 188 |
| 2025 5 | 117 | 47 | 164 |
| 2025 4 | 81 | 30 | 111 |
| 2025 3 | 130 | 62 | 192 |
| 2025 2 | 87 | 38 | 125 |
| 2025 1 | 70 | 27 | 97 |
| 2024 12 | 62 | 44 | 106 |
| 2024 11 | 77 | 51 | 128 |
| 2024 10 | 58 | 60 | 118 |
| 2024 9 | 63 | 65 | 128 |
| 2024 8 | 82 | 85 | 167 |
| 2024 7 | 51 | 46 | 97 |
| 2024 6 | 64 | 58 | 122 |
| 2024 5 | 76 | 43 | 119 |
| 2024 4 | 39 | 45 | 84 |
| 2024 3 | 38 | 22 | 60 |
| 2024 2 | 35 | 44 | 79 |
| 2024 1 | 26 | 29 | 55 |
| 2023 12 | 37 | 29 | 66 |
| 2023 11 | 34 | 40 | 74 |
| 2023 10 | 72 | 43 | 115 |
| 2023 9 | 80 | 30 | 110 |
| 2023 8 | 55 | 31 | 86 |
| 2023 7 | 66 | 25 | 91 |
| 2023 6 | 46 | 35 | 81 |
| 2023 5 | 44 | 34 | 78 |
| 2023 4 | 45 | 16 | 61 |
| 2023 3 | 56 | 20 | 76 |
| 2023 2 | 26 | 15 | 41 |
| 2023 1 | 40 | 14 | 54 |
| 2022 12 | 53 | 34 | 87 |
| 2022 11 | 57 | 39 | 96 |
| 2022 10 | 44 | 54 | 98 |
| 2022 9 | 50 | 43 | 93 |
| 2022 8 | 65 | 37 | 102 |
| 2022 7 | 32 | 43 | 75 |
| 2022 6 | 54 | 34 | 88 |
| 2022 5 | 69 | 44 | 113 |
| 2022 4 | 65 | 40 | 105 |
| 2022 3 | 86 | 55 | 141 |
| 2022 2 | 44 | 34 | 78 |
| 2022 1 | 91 | 38 | 129 |
| 2021 12 | 73 | 41 | 114 |
| 2021 11 | 63 | 36 | 99 |
| 2021 10 | 63 | 41 | 104 |
| 2021 9 | 57 | 35 | 92 |
| 2021 8 | 43 | 46 | 89 |
| 2021 7 | 60 | 41 | 101 |
| 2021 6 | 25 | 18 | 43 |
| 2021 5 | 40 | 30 | 70 |
| 2021 4 | 55 | 24 | 79 |
| 2021 3 | 48 | 42 | 90 |
| 2021 2 | 44 | 23 | 67 |
| 2021 1 | 36 | 19 | 55 |
| 2020 12 | 39 | 14 | 53 |
| 2020 11 | 36 | 13 | 49 |
| 2020 10 | 19 | 20 | 39 |
| 2020 9 | 21 | 10 | 31 |
| 2020 8 | 53 | 7 | 60 |
| 2020 7 | 40 | 15 | 55 |
| 2020 6 | 28 | 11 | 39 |
| 2020 5 | 44 | 10 | 54 |
| 2020 4 | 44 | 17 | 61 |
| 2020 3 | 43 | 13 | 56 |
| 2020 2 | 52 | 26 | 78 |
| 2020 1 | 41 | 21 | 62 |
| 2019 12 | 52 | 20 | 72 |
| 2019 11 | 35 | 24 | 59 |
| 2019 10 | 20 | 8 | 28 |
| 2019 9 | 27 | 11 | 38 |
| 2019 8 | 19 | 12 | 31 |
| 2019 7 | 35 | 22 | 57 |
| 2019 6 | 29 | 12 | 41 |
| 2019 5 | 35 | 16 | 51 |
| 2019 4 | 66 | 34 | 100 |
| 2019 3 | 34 | 21 | 55 |
| 2019 2 | 28 | 27 | 55 |
| 2019 1 | 23 | 16 | 39 |
| 2018 12 | 67 | 31 | 98 |
| 2018 11 | 103 | 16 | 119 |
| 2018 10 | 70 | 15 | 85 |
| 2018 9 | 56 | 13 | 69 |
| 2018 8 | 45 | 16 | 61 |
| 2018 7 | 46 | 14 | 60 |
| 2018 6 | 36 | 17 | 53 |
| 2018 5 | 36 | 14 | 50 |
| 2018 4 | 51 | 5 | 56 |
| 2018 3 | 50 | 14 | 64 |
| 2018 2 | 37 | 9 | 46 |
| 2018 1 | 53 | 10 | 63 |
| 2017 12 | 45 | 12 | 57 |
| 2017 11 | 41 | 9 | 50 |
| 2017 10 | 36 | 16 | 52 |
| 2017 9 | 39 | 9 | 48 |
| 2017 8 | 39 | 10 | 49 |
| 2017 7 | 35 | 9 | 44 |
| 2017 6 | 33 | 11 | 44 |
| 2017 5 | 44 | 11 | 55 |
| 2017 4 | 28 | 11 | 39 |
| 2017 3 | 26 | 4 | 30 |
| 2017 2 | 21 | 4 | 25 |
| 2017 1 | 28 | 11 | 39 |
| 2016 12 | 45 | 3 | 48 |
| 2016 11 | 43 | 6 | 49 |
| 2016 10 | 46 | 7 | 53 |
| 2016 9 | 110 | 7 | 117 |
| 2016 8 | 140 | 6 | 146 |
| 2016 7 | 135 | 9 | 144 |
| 2016 6 | 88 | 0 | 88 |
| 2016 5 | 129 | 0 | 129 |
| 2016 4 | 95 | 0 | 95 |
| 2016 3 | 96 | 0 | 96 |
| 2016 2 | 96 | 0 | 96 |
| 2016 1 | 102 | 0 | 102 |
| 2015 12 | 103 | 0 | 103 |
| 2015 11 | 84 | 0 | 84 |
| 2015 10 | 84 | 0 | 84 |
| 2015 9 | 68 | 0 | 68 |
| 2015 8 | 72 | 0 | 72 |
| 2015 7 | 74 | 0 | 74 |
| 2015 6 | 33 | 0 | 33 |
| 2015 5 | 57 | 0 | 57 |
| 2015 4 | 6 | 0 | 6 |
Show all
